Lv11
94 积分 2023-05-10 加入
Antigen identification and high-throughput interaction mapping by reprogramming viral entry
5小时前
已完结
Zevorcabtagene Autoleucel: First Approval
11个月前
已完结
CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia
1年前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
1年前
已完结
皖公网安备34019202002308
